GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $182,595,000 | +17749.0% | 841,840 | +9401.6% | 0.13% | +12900.0% |
| Q4 2020 | $1,023,000 | -76.7% | 8,860 | -82.3% | 0.00% | -90.0% |
| Q1 2020 | $4,393,000 | -78.7% | 50,165 | -74.5% | 0.01% | -61.5% |
| Q4 2019 | $20,597,000 | -81.2% | 196,989 | -79.3% | 0.03% | -85.0% |
| Q3 2019 | $109,711,000 | +3081.9% | 953,767 | +4668.8% | 0.17% | +3360.0% |
| Q2 2019 | $3,448,000 | -77.3% | 20,000 | -77.8% | 0.01% | -78.3% |
| Q1 2019 | $15,218,000 | -3.0% | 90,279 | -43.9% | 0.02% | -4.2% |
| Q4 2018 | $15,685,000 | +243.4% | 161,058 | +392.0% | 0.02% | +300.0% |
| Q2 2018 | $4,568,000 | -83.1% | 32,734 | -86.3% | 0.01% | -83.3% |
| Q1 2018 | $27,015,000 | +3.1% | 239,774 | +20.8% | 0.04% | 0.0% |
| Q4 2017 | $26,194,000 | +834.2% | 198,425 | +618.1% | 0.04% | +800.0% |
| Q3 2017 | $2,804,000 | -82.3% | 27,633 | -82.5% | 0.00% | -85.7% |
| Q2 2017 | $15,869,000 | -18.2% | 158,290 | -1.3% | 0.03% | -22.2% |
| Q1 2017 | $19,400,000 | -29.1% | 160,402 | -34.5% | 0.04% | -36.8% |
| Q4 2016 | $27,377,000 | +24.4% | 244,980 | +47.7% | 0.06% | +54.1% |
| Q3 2016 | $22,012,000 | +3789.0% | 165,838 | +2585.2% | 0.04% | +3600.0% |
| Q2 2016 | $566,000 | -98.4% | 6,176 | -98.7% | 0.00% | -98.9% |
| Q1 2016 | $34,921,000 | +10579.2% | 483,999 | +10182.5% | 0.09% | +8600.0% |
| Q4 2015 | $327,000 | -88.2% | 4,707 | -84.5% | 0.00% | -80.0% |
| Q3 2015 | $2,770,000 | -2.3% | 30,316 | +31.4% | 0.01% | 0.0% |
| Q2 2015 | $2,835,000 | +19.6% | 23,080 | -11.3% | 0.01% | +25.0% |
| Q1 2015 | $2,371,000 | +250.2% | 26,020 | +160.2% | 0.00% | +300.0% |
| Q4 2014 | $677,000 | -44.9% | 10,000 | -34.2% | 0.00% | -66.7% |
| Q3 2014 | $1,229,000 | -76.1% | 15,200 | -68.2% | 0.00% | -78.6% |
| Q2 2014 | $5,134,000 | +1600.0% | 47,850 | +839.3% | 0.01% | +1300.0% |
| Q1 2014 | $302,000 | -95.2% | 5,094 | -96.6% | 0.00% | -95.0% |
| Q4 2013 | $6,268,000 | +448.9% | 150,897 | +129.0% | 0.02% | +400.0% |
| Q3 2013 | $1,142,000 | – | 65,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |